Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma

Clinical trial NCT06767306 · RECRUITING

Trial details

NCT number: NCT06767306
Sponsor: Melanoma Institute Australia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Metastatic

Start date: 2025-03-06
Primary completion: 2033-04-01
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.